Also Read: Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues The mean exposure duration in BEACON-IPF was approximately 17 weeks. Overall, the percentage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback